Medication beliefs are associated with phosphate binder non-adherence in hyperphosphatemic haemodialysis patients

British Journal of Health Psychology

Volumn 20, Issue 3, 2015, Pages 563-578

  Wileman, Vari ^a   Farrington, Ken ^b   Wellsted, David ^a   Almond, Mike ^c   Davenport, Andrew ^d   Chilcot, Joseph ^e  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^b LISTER HOSPITAL   (United Kingdom)

^c SOUTHEND UNIVERSITY HOSPITAL   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

adherence; haemodialysis; hyperphosphatemia; medication beliefs; phosphate binders

Indexed keywords

CHELATING AGENT;

ADULT; AGED; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HUMAN; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PSYCHOLOGY; QUESTIONNAIRE; RENAL REPLACEMENT THERAPY;

ADULT; AGED; ATTITUDE TO HEALTH; CHELATING AGENTS; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HUMANS; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RENAL DIALYSIS; SURVEYS AND QUESTIONNAIRES;

EID: 84937946964     PISSN: 1359107X     EISSN: 20448287     Source Type: Journal    
DOI: 10.1111/bjhp.12116     Document Type: Article

References (32)

1. Akman, B.; Uyar, M.; Afsar, B.; Sezer, S.; Nurhan Ozdemir, F.; &, Haberal, M.; (2007). Adherence, depression and quality of life in patients on a renal transplantation waiting list. Transplant International, 20, 682-687. doi: 10.1111/j.1432-2277.2007.00495.x
2. Block, G. A.; Hulbert-Shearon, T. E.; Levin, N. W.; &, Port, F. K.; (1998). Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: A national study. American Journal of Kidney Diseases, 31, 607-617. doi: 10.1053/ajkd.1998.v31.pm9531176
3. Charlson, M. E.; Pompei, P.; Ales, K. L.; &, MacKenzie, C. R.; (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40, 373-383. doi: 10.1016/0021-9681(87)90171-8
4. Chilcot, J.; Davenport, A.; Wellsted, D.; Firth, J.; &, Farrington, K.; (2011). An association between depressive symptoms and survival in incident dialysis patients. Nephrology Dialysis Transplantation, 26, 1628-1634. doi: 10.1093/ndt/gfq611
5. Chilcot, J.; Norton, S.; Wellsted, D.; Davenport, A.; Firth, J.; &, Farrington, K.; (2013). Distinct depression symptom trajectories over the first year of dialysis: Associations with illness perceptions. [Research Support, Non-U.S. Gov't]. Annals of Behavioral Medicine, 45 (1), 78-88. doi: 10.1007/s12160-012-9410-5
6. Chilcot, J.; Wellsted, D.; Da Silva-Gane, M.; &, Farrington, K.; (2008). Depression on dialysis [Review]. Nephron Clinical Practice, 108, c256-c264. doi: 10.1159/000124749
7. Chiu, Y.-W.; Teitelbaum, I.; Misra, M.; de Leon, E. M.; Adzize, T.; &, Mehrotra, R.; (2009). Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clinical Journal of the American Society of Nephrology, 4, 1089-1096. doi: 10.2215/CJN.00290109
8. Clark, S.; Farrington, K.; &, Chilcot, J.; (2014). Nonadherence in dialysis patients: Prevalence, measurement, outcome, and psychological determinants. Seminars in dialysis, 27 (1), 42-49. doi: 10.1111/sdi.12159
9. Clifford, S.; Barber, N.; &, Horne, R.; (2008). Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: Application of the necessity-concerns framework. Journal of Psychosomatic Research, 64 (1), 41-46. doi: 10.1016/j.jpsychores.2007.05.004
10. Daugirdas, J. T.; Finn, W. F.; Emmett, M.; &, Chertow, G. M.; (2011). The phosphate binder equivalent dose. Seminars in Dialysis, 24 (1), 41-49. doi: 10.1111/j.1525-139X.2011.00849.x
11. Denhaerynck, K.; Manhaeve, D.; Dobbels, F.; Garzoni, D.; Nolte, C.; &, De Geest, S.; (2007). Prevalence and consequences of nonadherence to hemodialysis regimens. American Journal of Critical Care, 16, 222-235.
12. DiMatteo, M. R.; Lepper, H. S.; &, Croghan, T. W.; (2000). Depression is a risk factor for noncompliance with medical treatmentmeta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160, 2101-2107. doi: 10.1001/archinte.160.14.2101
13. Horne, R.; Chapman, S. C.; Parham, R.; Freemantle, N.; Forbes, A.; &, Cooper, V.; (2013). Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: A meta-analytic review of the necessity-concerns framework. PLoS ONE, 8, e80633. doi: 10.1371/journal.pone.0080633
14. Horne, R.; Sumner, S.; Jubraj, B.; Weinman, J.; &, Frost, S.; (2001). Haemodialysis patients' beliefs about treatment: Implications for adherence to medication and fluid-diet restrictions. The International Journal of Pharmacy Practice, 9, 169-175. doi: 10.1111/j.2042-7174.2001.tb01045.x
15. Horne, R.; &, Weinman, J.; (1999). patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research, 47 (6), 555-567. doi: 10.1016/S0022-3999(99)00057-4
16. Horne, R.; &, Weinman, J.; (2002). Self-regulation and self-management in asthma: Exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychology and Health, 17 (1), 17-32. doi: 10.1080/08870440290001502
17. Horne, R.; Weinman, J.; &, Hankins, M.; (1999). The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology and Health, 14 (1), 1-24. doi: 10.1080/08870449908407311
18. Jamal, S. A.; Vandermeer, B.; Raggi, P.; Mendelssohn, D. C.; Chatterley, T.; Dorgan, M.;...; Tsuyuki, R. T.; (2013). Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: An updated systematic review and meta-analysis. The Lancet, 382, 1268-1277. doi: 10.1016/S0140-6736(13)60897-1
19. Karamanidou, C.; Clatworthy, J.; Weinman, J.; &, Horne, R.; (2008). A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrology, 9, 2. doi: 10.1186/1471-2369-9-2
20. Karamanidou, C.; Weinman, J.; &, Horne, R.; (2008). Improving haemodialysis patients' understanding of phosphate-binding medication: A pilot study of a psycho-educational intervention designed to change patients' perceptions of the problem and treatment. British Journal of Health Psychology, 13 (Pt 2), 205-214. doi: 10.1348/135910708X288792
21. Khalil, A. A.; &, Frazier, S. K.; (2010). Depressive symptoms and dietary nonadherence in patients with end-stage renal disease receiving hemodialysis: A review of quantitative evidence. Issues in Mental Health Nursing, 31, 324-330. doi: 10.3109/01612840903384008
22. Kroenke, K.; Spitzer, R. L.; &, Williams, J. B.; (2001). The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine, 16, 606-616. doi: 10.1046/j.1525-1497.2001.016009606.x
23. Lindberg, M.; &, Lindberg, P.; (2008). Overcoming obstacles for adherence to phosphate binding medication in dialysis patients: A qualitative study. Pharmacy World and Science, 30, 571-576. doi: 10.1007/s11096-008-9212-9
24. Long, J.; Kee, C.; Graham, M.; Saethang, T.; &, Dames, F.; (1998). Medication compliance and the older hemodialysis patient. ANNA Journal/American Nephrology Nurses' Association, 25 (1), 43.
25. Nicholas, J.; Shaw, C.; Pitcher, D.; &, Dawnay, A.; (2014). UK Renal Registry 16th annual report: Chapter 12 biochemical variables amongst UK adult dialysis patients in 2012: National and Centre-Specific Analyses. Nephron Clinical Practice, 125, 219-258. doi: 10.1159/000360031
26. Pruthi, R.; Pitcher, D.; &, Dawnay, A.; (2012). Biochemical variables amongst UK adult dialysis patients in 2010: National and Centre-Specific Analyses. Nephron Clinical Practice, 120 (Suppl. 1), c175-c210. doi: 10.1159/000342852
27. Schmid, H.; Hartmann, B.; &, Schiffl, H.; (2009). Adherence to prescribed oral medication in adult patients undergoing chronic hemodialysis: A critical review of the literature. European Journal of Medical Research, 14, 185. doi: 10.1186/2047-783X-14-5-185
28. Schmid, H.; Schiffl, H.; &, Lederer, S. R.; (2010). Pharmacotherapy of end-stage renal disease. Expert Opinion on Pharmacotherapy, 11, 597-613. doi: 10.1517/14656560903544494
29. Steenkamp, R.; Shaw, C.; &, Feest, T.; (2013). UK Renal Registry 15th annual report: Chapter 5 survival and causes of death of UK adult patients on renal replacement therapy in 2011: National and Centre-Specific Analyses. Nephron Clinical Practice, 123 (Suppl. 1), 93-123. doi: 10.1159/000353324
30. Tracy, H. M.; Green, C.; &, McCleary, J.; (1987). Noncompliance in hemodialysis patients as measured with the MBHI. Psychology and Health, 1, 411-423. doi: 10.1080/08870448708400340
31. Wileman, V.; Chilcot, J.; Norton, S.; Hughes, L.; Wellsted, D.; &, Farrington, K.; (2011). Choosing not to take phosphate binders: The role of dialysis patients' medication beliefs. Nephron Clinical Practice, 119, c205-c213. doi: 10.1159/000329106
32. Wileman, V.; Farrington, K.; Chilcot, J.; Norton, S.; Wellsted, D. M.; Almond, M.;...; Armitage, C.; (2014). Evidence that self-affirmation improves phosphate control in hemodialysis patients: A pilot cluster randomized controlled trial. Annals of Behavioral Medicine. 48, 275-281. doi: 10.1007/s12160-014-9597-8